Search clinical trials for: Immunoblastic NHL

Total 5225 results

Arvinas Inc.

Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) | Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)

United States, Spain
Peking Union Medical College Hospital
Beijing Longfu Hospital

Not yet recruiting

Azacytidine Plus Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic T-cell Lymphoma

Angioimmunoblastic T-cell Lymphoma

China
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital; Genzyme, a Sanofi...

Completed

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Follicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | Anaplastic Large-cell Lymphoma | Low Grade B-cell Lymphoma, Not Otherwise Specified

United States
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...

Completed

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Immunoblastic

United States
Mayo Clinic

Completed

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditions

United States, Italy
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult... and other conditions

United States, Germany, Italy
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Clear Cell Renal Cell Carcinoma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent... and other conditions

United States, Germany, Italy
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

Stage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditions

United States, Germany, Italy
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell Lymphoma and other conditions

United States
University of Southern California

Terminated

Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

Non-Hodgkin's Lymphoma | Burkitt Lymphoma | Primary Effusion Lymphomas

United States
Boehringer Ingelheim

Completed

Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)

Lymphoma

United States
Scotland and Newcastle Lymphoma Group

Unknown

Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

Lymphoma

United Kingdom
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

Lymphoma

United States
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Investigating Dyadic Expectations About ARF Survivorship (IDEAS) (IDEAS)

Acute Respiratory Failure | Mental Health Issue | Caregiving Stress

United States
Duke University
University of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes (PROMISE)

Lung Transplant Rejection | Lung Transplant Failure | Lung Transplant; Complications | Lung Transplant; Infection or Inflammation
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI); University of Michigan; University... and other collaborators

Recruiting

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease (MOUNTAIN)

Rheumatoid Arthritis | Interstitial Lung Disease

United States
Dren Bio
Novotech (Australia) Pty Limited

Recruiting

A Study of DR-0201 in Subjects With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

B-cell Non Hodgkin Lymphoma

Australia, Hong Kong, Korea, Republic of, Singapore, Taiwan
University of Massachusetts, Worcester
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Recruiting

Asthma Link Effectiveness Trial: Cluster Randomized Controlled Trial

Childhood Asthma

United States
University of California, San Diego
Mayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Yale University; Brigham and Women's Hospital and other collaborators

Recruiting

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping (EPIPHANY)

Moderate to Severe Asthma

United States
Boston Immune Technologies and Therapeutics

Not yet recruiting

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

Peripheral T-cell Lymphoma | NHL | Cutaneous T Cell Lymphoma
Oregon State University
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Shift Worker Intervention for Sleep Health (SWISH)

Insomnia, Psychophysiological | Shift Work Type Circadian Rhythm Sleep Disorder

United States
JHSPH Center for Clinical Trials
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Multi-Center Clean Air Randomized Controlled Trial in COPD (Clean Air)

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Pittsburgh
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain (PRESENCE)

Pain | Sickle Cell Disease
St. Jude Children's Research Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

School Readiness Intervention for Preschool Children With Sickle Cell Disease

Sickle Cell Disease

United States
Ohio State University
National Heart, Lung, and Blood Institute (NHLBI); University of Utah

Not yet recruiting

Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART)

Wounds and Injuries | Critical Illness | Child, Only | Heart Arrest, Out-Of-Hospital | Respiratory Insufficiency in Children
Ruijin Hospital
The First Affiliated Hospital with Nanjing Medical University; Shanghai Longyao...

Recruiting

An Evaluation of LY007 Cell Injection for r/r B-NHL (r/r B-NHL)

B-NHL

China
Ruijin Hospital

Not yet recruiting

CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors

B-NHL, Extranodal, TP53 Alterations, Bulky Mass
University of California, Los Angeles
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in Los Angeles County

Hypertension

United States
Mayo Clinic
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Recruiting

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

Malignant Solid Neoplasm | Hematopoietic and Lymphatic System Neoplasm

United States
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury

Thrombocytopenia | Surgery | Acute Kidney Injury | Hemolysis

United States
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

RESTORE - Phase II

Maternal Health

United States
Stanford University
National Heart, Lung, and Blood Institute (NHLBI); University of Texas; Carelon...

Not yet recruiting

Pumps for Kids, Infants and Neonates (PumpKIN): The Jarvik 2015 Pivotal Trial (PumpKIN)

Heart Failure With Reduced Ejection Fraction | LVAD | Pediatric HD, Stage IV
Zhejiang University
Shanghai YaKe Biotechnology Ltd.

Not yet recruiting

CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL

Non-hodgkin Lymphoma,B Cell | Acute Lymphoblastic Leukemia,B-Cell

China
Estrella Biopharma, Inc.
Eureka Therapeutics Inc.

Not yet recruiting

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) (Starlight-1)

Lymphoma | Lymphoma, Non-Hodgkin | Non-Hodgkin's Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | CNS Lymphoma | Lymphomas Non-Hodgkin's B-Cell | Relapsed Non-Hodgkin Lymphoma | Lymphoma, Non-Hodgkins | Large B-Cell Lymphoma and other conditions
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI); Francis Family Foundation

Not yet recruiting

Improving Psychological Outcomes for Acute Respiratory Failure Survivors Using a Self-Management Intervention (SMARA)

Critical Illness | Respiratory Failure | Anxiety
Arizona State University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women

Heart Diseases | Diabetes Mellitus | Physical Activity | Exercise | Physical Inactivity

United States
Emory University
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Bioenergetic Effect of Pioglitazone in CLD-PH

Pulmonary Hypertension | Pulmonary Hypertension Due to Lung Diseases
China-Japan Friendship Hospital

Recruiting

Establishment of Precise Nutrition Management Scheme for Patients With Prediabetes Based on Nutrigenomics

Prediabetes

China
Brigham and Women's Hospital
University of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI); Beth Israel Deaconess Medical Center and other collaborators

Not yet recruiting

Adult Sleep Health in the Rural Appalachia and Mississippi Delta Region and Its Relationships With Cardiometabolic Health Disparities.

Fatigue | Insomnia | Sleep Apnea | Sleep Deprivation | Sleep Disorders, Circadian Rhythm | Sleepiness, Excessive Daytime

United States
Denice Hodgson-Zingman, MD
National Heart, Lung, and Blood Institute (NHLBI); The Cleveland Clinic; National...

Not yet recruiting

Paced Heart Rate Acceleration for Cardiac Conditioning (HeartExcel)

Heart Failure, Systolic
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Transplanting Lungs From Uncontrolled Donation After Circulatory Death

Lung Transplantation

United States
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors

Cardiovascular Diseases | Lifestyle Factors

United States
University of Virginia
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
Chinese PLA General Hospital

Recruiting

Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL

Non-hodgkin Lymphoma,B Cell

China
Guangdong Ruishun Biotech Co., Ltd
Ruijin Hospital; Southern Medical University, China; Beijing GoBroad Hospital

Not yet recruiting

A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL

B-cell Non-Hodgkin's Lymphoma
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

teleABLE to Reduce Post-Stroke Sedentary Behavior

Stroke

United States
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)

Obstructive Sleep Apnea

United States
National Heart, Lung, and Blood Institute (NHLBI)
Children's National Research Institute

Recruiting

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Sickle Cell Disease | Thalassemia | Hemoglobinopathy

United States
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure (HALT-RHF)

Pulmonary Hypertension | Heart Failure With Reduced Ejection Fraction | Right Heart Failure Due to Left Heart Failure

Search clinical trials for: Immunoblastic NHL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations